Literature DB >> 8026882

Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma.

G J Walker1, J M Palmer, M K Walters, D J Nancarrow, P G Parsons, N K Hayward.   

Abstract

Karyotypic analysis, loss of somatic heterozygosity, microcell fusion and cDNA transfection studies have provided compelling evidence that at least one tumour suppressor gene for melanoma resides on chromosome 6. In an attempt to further define the regions to which these putative suppressor genes map, we have carried out loss of heterozygosity (LOH) studies on DNA from 25 fresh melanoma tumours for 9 simple tandem repeat (STR) polymorphism markers spanning chromosome 6. Four samples displayed LOH or homozygosity for all markers studied, indicating that they had lost one homologue of chromosome 6. An additional 3 samples showed LOH for all markers on 6q. Furthermore, 30 melanoma cell lines, for which there were no matching somatic DNA samples, were analyzed for hemizygosity of markers on 6q. One cell line had a homozygous deletion of all markers tested and a further 12 cell lines displayed only one allele for 3 or 4 contiguous markers, indicating that most, if not all of these samples were hemizygous for the region of 6q distal to D6S87. Overall, the rate of LOH on 6q in the 55 melanoma DNAs was 35%, and there were no losses of markers on 6p without concomitant loss of markers on 6q. Two of 5 samples derived from primary melanomas showed LOH, which indicates that LOH for the melanoma suppressor gene on 6q, which maps to a region that contains the SOD2 locus, is a frequent and early event in melanoma tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026882     DOI: 10.1002/ijc.2910580210

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 2.  Genetic pathways to melanoma tumorigenesis.

Authors:  M R Hussein
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

3.  hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer.

Authors:  A Varrault; E Ciani; F Apiou; B Bilanges; A Hoffmann; C Pantaloni; J Bockaert; D Spengler; L Journot
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.

Authors:  J M Karjalainen; J K Kellokoski; A J Mannermaa; H E Kujala; K I Moisio; P J Mitchell; M J Eskelinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 5.  Insights into the Dichotomous Regulation of SOD2 in Cancer.

Authors:  Yeon Soo Kim; Piyushi Gupta Vallur; Rébécca Phaëton; Karthikeyan Mythreye; Nadine Hempel
Journal:  Antioxidants (Basel)       Date:  2017-11-03

Review 6.  SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.

Authors:  Nouralhuda Alateyah; Ishita Gupta; Radoslaw Stefan Rusyniak; Allal Ouhtit
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

7.  Molecular mechanism underlying differential apoptosis between human melanoma cell lines UACC903 and UACC903(+6) revealed by mitochondria-focused cDNA microarrays.

Authors:  Qiuyang Zhang; Jun Wu; Anhthu Nguyen; Bi-Dar Wang; Ping He; Georges St Laurent; Owen M Rennert; Yan A Su
Journal:  Apoptosis       Date:  2008-08       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.